Qube Research & Technologies Ltd

Position in GRFS — Grifols SA

CIK 1729829 LONDON, X0

Position in GRFS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,875,095

+$1,107,672 QoQ

Shares Held

406,087

+84.3% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#31

of 164 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $1,498,530,307 across 11 Drug Manufacturers - General names. GRFS ranks #11 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	346,498	$415,600,130
2	GILD	Gilead Sciences, Inc.	3,086,166	$389,906,212
3	JNJ	Johnson & Johnson	752,337	$191,071,027
4	BMY	Bristol Myers Squibb Co	3,093,958	$178,273,859
5	MRK	Merck & Co., Inc.	1,044,210	$134,180,985
6	AZN	Astrazeneca PLC	375,473	$71,197,190
7	GSK	GSK plc	1,078,767	$56,548,966
8	SNY	Sanofi	634,794	$27,080,312

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,875,095	406,087	+84.3%	Shares	Sole	2026-08-14
2026-03-31	$1,767,423	220,377	+22.1%	Shares	Sole	2026-05-15
2025-12-31	$1,687,160	180,445	+87.8%	Shares	Sole	2026-02-17
2025-09-30	$957,036	96,088	+419.1%	Shares	Sole	2025-11-14
2023-12-31	$213,975	18,510	-96.4%	Shares	Sole	2024-02-13
2022-09-30	$3,160,055	512,996	+415.7%	Shares	Sole	2022-11-14
2022-03-31	$1,161,984	99,485	-58.7%	Shares	Sole	2022-05-09
2021-12-31	$2,703,195	240,712	+1948.8%	Shares	Sole	2022-02-10
2021-09-30	$171,652	11,749	-82.1%	Shares	Sole	2021-11-12
2020-12-31	$1,212,171	65,736	+66.5%	Shares	Sole	2021-02-16
2020-09-30	$684,804	39,470	-88.7%	Shares	Sole	2020-11-12
2020-06-30	$6,385,149	350,063	+1481.5%	Shares	Sole	2020-08-14
2020-03-31	$445,798	22,135	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.